Session 63: Ex uteroTuesday 11th May, 2021. 3PM EST/ 8PM GMT / 9PM CET
Moderators: Prof. Susana Chuva de Sousa Lopes and Prof. David Albertini
"Brave New Lab-An Introduction to the Latest Developments"
Prof. David Albertini
"Symmetry Breaking in the Human Embryo"
"In vitro Culture of Post-implantation Embryos"
and "Ex utero Mouse Embryogenesis from Pre-gastrulation to Advanced Organogenesis"
Alejandro Aguilera Castrejon
ALEJANDRO AGUILERA CASTREJON
PROF. SUSANA M. CHUVA DE SOUSA LOPES
PROF DAVID ALBERTINI
David Albertini received his Ph.D. from Harvard University working on the cell biology of the mammalian ovary. After postdoctoral work at the University of Connecticut Health Center, he returned to Harvard Medical School as an Assistant Professor of Anatomy and Cell Biology until 1984, and was an Associate Professor and Professor at Tufts University School of Medicine up to 2004. At Tufts, he served as Chair of the Department of Anatomy and Cell Biology (1996-2000), Director of the Center for Reproduction (1999-2003) and Director of the Confocal Microscopy core (1988-1999). From 2004-2016, he held the Hall Professor of Molecular Medicine Chair at the Kansas University Medical Center where he continued his career long interests in biomedical imaging and oocyte and embryo development, as it pertains to the practice of human Assisted Reproduction Technologies.
He currently serves as Visiting Senior Scientist at The Center for Human Reproduction and The Rockefeller University in New York City and Professor of Reproductive Cell Biology at the Bedford Research Foundation (MA). Since 2009, he has been the Editor-in-Chief of the Journal of Assisted Reproduction and Genetics (JARG), and has been the recipient of many awards including a Basil O’Connor fellowship from the March of Dimes, the Hammond Medal from the Society for Reproduction and Fertility (UK), the Founder’s Lecturer for the Australian Society of Reproductive Biology, The Beacon Award from Frontiers in Reproduction among others. He has served on scientific advisory boards for the National Science Foundation, National Institutes of Health, American Cancer Society and grant review councils in Scotland, England, Portugal, Italy, Belgium, and Turkey and continues to advocate for fair use of ARTs in patient care based on sound scientific principles.